BioNeutra Global Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CAD 15.4 million compared to CAD 24.12 million a year ago. Net loss was CAD 2.83 million compared to CAD 3.71 million a year ago. Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.08 a year ago. Diluted loss per share from continuing operations was CAD 0.06 compared to CAD 0.08 a year ago.